Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-04-30 @ 12:25 PM
Study NCT ID:
NCT04579757
Status:
TERMINATED
Last Update Posted:
2025-05-08
First Post:
2020-09-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Sponsor:
Organization: